riluzole has been researched along with Angiogenesis, Pathologic in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, Y | 1 |
| Gao, M | 1 |
| Zhou, T | 1 |
| Xie, M | 1 |
| Mao, A | 1 |
| Feng, L | 1 |
| Yao, X | 1 |
| Wong, WT | 1 |
| Ma, X | 1 |
| Wen, Y | 1 |
| Li, J | 1 |
| Koo, J | 1 |
| Shin, SS | 1 |
| Lin, Y | 1 |
| Jeong, BS | 1 |
| Mehnert, JM | 1 |
| Chen, S | 1 |
| Cohen-Sola, KA | 1 |
| Goydos, JS | 1 |
2 other studies available for riluzole and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The TRPC5 channel regulates angiogenesis and promotes recovery from ischemic injury in mice.
Topics: Animals; Disease Models, Animal; Endothelial Cells; HEK293 Cells; Humans; Ischemia; Mice; Mice, Knoc | 2019 |
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Heterocyclic Compounds, 3-Ring; Humans; Hypoxia-Ind | 2014 |